COVID-19 vaccines

• 

  Subject Areas on Research

  • A Bivalent Omicron-Containing Booster Vaccine against Covid-19. 
  • A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice. 
  • A genetically engineered, stem-cell-derived cellular vaccine. 
  • A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates. 
  • Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19. 
  • Adults Hospitalized With Coronavirus Disease 2019 (COVID-19)-United States, March-June and October-December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and Outcomes. 
  • American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3. 
  • American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4. 
  • American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5. 
  • An ethical framework for global vaccine allocation. 
  • Antibodies, boosters, and optimizing SARS-CoV-2 vaccines for transplantation: A call for more research. 
  • Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development? 
  • Archbishop Desmond Tutu and the universality of health and human rights. 
  • Ascertainment of vaccination status by self-report versus source documentation: Impact on measuring COVID-19 vaccine effectiveness. 
  • Assessing the Impact of COVID-19 on the Health of Native Hawaiian/Pacific Islander People in the United States, 2021. 
  • Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity. 
  • Association of State COVID-19 Vaccination Prioritization With Vaccination Rates Among Incarcerated Persons. 
  • Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV. 
  • Attitudes and Beliefs of Patients With Left-Ventricular Assist Devices Toward COVID-19 Vaccination and Willingness to Seek Care During the Pandemic. 
  • Axillary adenopathy detected on breast MRI following COVID-19 vaccination: outcomes and follow-up recommendations. 
  • Breakthrough SARS-CoV-2 Infections in Prison after Vaccination. 
  • COVID-19 Vaccination Rates in a Global HIV Cohort. 
  • COVID-19 Vaccination and Obesity: Optimism and Challenges. 
  • COVID-19 Vaccine-Related Axillary Adenopathy on Breast Imaging: Follow-Up Recommendations and Histopathologic Findings. 
  • COVID-19 and the Uncovering of Health Care Disparities in the United States, United Kingdom and Canada: Call to Action. 
  • COVID-19 vaccination in individuals with spina bifida: A national survey. 
  • COVID-19 vaccination intention and activation among health care system employees: A mixed methods study. 
  • COVID-19 vaccine deliberation in individuals directly impacted by incarceration. 
  • COVID-19 vaccine hesitancy among low-income, racially and ethnically diverse US parents. 
  • COVID-19 vaccine prioritization of incarcerated people relative to other vulnerable groups: An analysis of state plans. 
  • Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Following COVID-19. 
  • Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination-United States, December 2020 to August 2021. 
  • Chimeric spike mRNA vaccines protect against sarbecovirus challenge in mice 
  • Clinical characteristics of COVID-19 in solid organ transplant recipients following COVID-19 vaccination: A multicenter case series. 
  • Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study. 
  • Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults: Suspected Myocarditis After COVID-19 Vaccination. 
  • Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021. 
  • Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States. 
  • Coronavirus Disease 2019 Vaccine in Children. 
  • Coronavirus disease 2019 vaccines in pregnancy. 
  • Corticosteroid Use in Otolaryngology: Current Considerations During the COVID-19 Era. 
  • D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization. 
  • Defining the risk of SARS-CoV-2 variants on immune protection. 
  • Determinants and Trends of COVID-19 Vaccine Hesitancy and Vaccine Uptake in a National Cohort of US Adults: A Longitudinal Study. 
  • Developing vaccines for neglected and emerging infectious diseases. 
  • Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents? 
  • Early Adoption of Anti-SARS-CoV-2 Pharmacotherapies Among US Veterans With Mild to Moderate COVID-19, January and February 2022. 
  • Effect of COVID-19 Vaccine Messaging Platforms in Emergency Departments on Vaccine Acceptance and Uptake: A Cluster Randomized Clinical Trial. 
  • Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial. 
  • Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial. 
  • Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial. 
  • Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization. 
  • Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021. 
  • Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States. 
  • Effectiveness of mRNA COVID-19 Vaccine Boosters Against Infection, Hospitalization, and Death: A Target Trial Emulation in the Omicron (B.1.1.529) Variant Era. 
  • Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021. 
  • Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States. 
  • Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial. 
  • Essential Strategies to Curb COVID-19 Transmission in Prisons and Jails. 
  • Estimating vaccine efficacy over time after a randomized study is unblinded. 
  • Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities. 
  • Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age. 
  • Examination of Adverse Reactions After COVID-19 Vaccination Among Patients With a History of Multisystem Inflammatory Syndrome in Children. 
  • Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine. 
  • Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination. 
  • Factors Associated With Parental Acceptance of COVID-19 Vaccination: A Multicenter Pediatric Emergency Department Cross-Sectional Analysis. 
  • Human rights and fair access to COVID-19 vaccines: the International AIDS Society-Lancet Commission on Health and Human Rights. 
  • Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial. 
  • Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates. 
  • Impact of Vaccination With the SCB-2019 Coronavirus Disease 2019 Vaccine on Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Household Contact Study in the Philippines. 
  • Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial. 
  • Incarcerated workers: overlooked as essential workers. 
  • Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment. 
  • Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year later. 
  • Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines. 
  • Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel - 33 U.S. Sites, January-March 2021. 
  • It is not too late to achieve global covid-19 vaccine equity. 
  • Lessons learned from frontline skilled nursing facility staff regarding COVID-19 vaccine hesitancy. 
  • Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study. 
  • Mitigation behavior prior to COVID-19 vaccination availability is associated with COVID-19 infection and time to vaccination. 
  • Multifactorial influences underpinning a decision on COVID-19 vaccination among healthcare workers: a qualitative analysis. 
  • Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021. 
  • Myocarditis Temporally Associated With COVID-19 Vaccination. 
  • NVX-CoV2373, a protein-based vaccine against SARS-CoV-2 infection. 
  • National COVID-19 vaccination plan: using artificial spatial intelligence to overcome challenges in Brazil. 
  • Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351. 
  • Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses. 
  • Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination status. 
  • Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study. 
  • Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19. 
  • Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination. 
  • Perspectives of COVID-19 vaccine-hesitant emergency department patients to inform messaging platforms to promote vaccine uptake. 
  • Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines. 
  • Predictors of willingness to get a COVID-19 vaccine in the U.S. 
  • Preventing pandemics in the world's most vulnerable settings. 
  • Profiteering from vaccine inequity: a crime against humanity? 
  • Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States. 
  • Rates of and Factors Associated With Primary and Booster COVID-19 Vaccine Receipt by US Veterans, December 2020 to June 2022. 
  • Relations of Current and Past Cancer with Severe Outcomes among 104,590 Hospitalized COVID-19 Patients: The COVID EHR Cohort at the University of Wisconsin. 
  • Reply to: Coronavirus disease 2019 vaccine in pregnant women: not so far! The importance of counseling and the need for evidence-based data. 
  • Reply: Coronavirus disease 2019 vaccines in pregnancy. 
  • Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients. 
  • SARS-CoV-2 Infection and Testing Experiences in a Nationwide Sample of Transgender and Gender-Diverse Adults, June-December 2021. 
  • SARS-CoV-2 Vaccines in Kidney Transplant Recipients: Will They Be Safe and Effective and How Will We Know? 
  • SARS-CoV-2 and HIV-1 - a tale of two vaccines. 
  • SARS-CoV-2 vaccination in pediatric patients with immune thrombocytopenia. 
  • SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study. 
  • SARS-CoV-2 vaccine acceptability among caregivers of childhood cancer survivors. 
  • SARS-CoV-2 vaccine safety and immunogenicity in patients with hematologic malignancies, transplantation, and cellular therapies. 
  • SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques. 
  • SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines. 
  • Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis. 
  • Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. 
  • Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial. 
  • Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine. 
  • Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques. 
  • Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021. 
  • The Quest for mRNA Vaccines. 
  • The need for inclusion of pregnant women in COVID-19 vaccine trials. 
  • The responsibilities of medical students in providing advice on the COVID-19 vaccination programme. 
  • Thrombocytopenia and splanchnic thrombosis after Ad26.COV2.S vaccination successfully treated with transjugular intrahepatic portosystemic shunting and thrombectomy. 
  • Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial. 
  • Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination. 
  • Towards a population-based threshold of protection for COVID-19 vaccines. 
  • Update in cutaneous manifestations of COVID-19: Special populations. 
  • Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study. 
  • Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know. 
  • Virology, Epidemiology, Pathogenesis, and Control of COVID-19. 
  • What are the key pediatric public policy priorities as the COVID-19 pandemic persists? 
  • [Not Available]. 
• 

  Keywords of People

  • Sadun, Rebecca Eli, Assistant Professor of Medicine, Medicine, Rheumatology and Immunology